Artificial Intelligence in the Assessment and Grading of Acne Vulgaris: A Systematic Review

Acne vulgaris is a common dermatological condition, particularly affecting adolescents during critical developmental stages, which may have lasting psychosocial impacts. Traditional assessments, including global severity grading and lesion counting, are limited by subjectivity and time constraints. Background/Objectives: This review aims to systematically assess the recent advancements in artificial intelligence (AI) applications for acne diagnosis, lesion segmentation/counting, and severity grading, highlighting the potential of AI-driven methods to improve objectivity, reproducibility, and clinical efficiency. Methods: A comprehensive literature search was conducted across PubMed, Scopus, arXiv, Embase, and Web of Science for studies published between 1 January 2017 and 1 March 2025. The search strategy incorporated terms related to "acne" and various AI methodologies (e.g., "neural network", "deep learning", "convolutional neural network"). Two independent reviewers screened 345 articles, with 29 studies ultimately meeting inclusion criteria. Data were extracted on study design, dataset characteristics (including internal and publicly available resources such as ACNE04 and AcneSCU), AI architectures (predominantly CNN-based models), and performance metrics. Results: While AI-driven models demonstrated promising accuracy, as high as 97.6% in controlled settings, the limited availability of large public datasets, the predominance of data from specific ethnic groups, and the lack of extensive external validation underscore critical barriers to clinical implementation. Conclusions: The findings indicate that although AI has the potential to standardize acne assessments, reduce observer variability, and enable self-monitoring via mobile platforms, significant challenges remain in achieving robust, real-world applicability. Future research should prioritize the development of large, diverse, and publicly accessible datasets and undertake prospective clinical validations to ensure equitable and effective dermatological care.